NIH-funded research R01 grant

Atomoxetine for MC4R obesity in children

Official title: Targeting BDNF Using Atomoxetine for the Treatment of Obesity Caused by MC4R Insufficiency

Funded at Research Inst Nationwide Children's Hosp · NIH-11586252 · Data updated 2026-11-12

A trial tests whether an ADHD drug, atomoxetine, can help children with a genetic form of obesity caused by MC4R mutations.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startJuly 1, 2025
Project endJune 30, 2028
Funding year2026
Award (this year)$351,553
NIH project number7R01DK142434-02
Project IDNIH-11586252 on NIH RePORTER

Who could benefit from this research

Could help

Children with MC4R loss-of-function variants causing obesity (MCOS) who meet study criteria and can be monitored for medication safety.

Less likely to help

Children without MC4R-related obesity or those with contraindications to atomoxetine may not benefit from this approach.

What this research studies

This project aims to repurpose atomoxetine to help kids with MC4R-related obesity, a condition where traditional treatments often fail. Researchers plan to explore how boosting BDNF signaling downstream of MC4R could reduce excessive hunger and help control weight. The study will involve a carefully monitored treatment approach in affected children, with outcomes focused on appetite, weight, and safety. By using an existing medication with known pharmacology, the team hopes to provide a faster path to an effective option for this specific genetic obesity syndrome.

Why it matters

Potential benefit: If successful, children with MC4R-associated obesity could experience better appetite control and weight management with a readily available medication.

How similar studies have gone: Prior animal and human data suggest atomoxetine can influence pathways relevant to MC4R signaling, but this exact pediatric MCOS application is novel.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Han, Joan Christine — Research Inst Nationwide Children's Hosp
  • Study coordinator: Han, Joan Christine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.